Vallette, F. M., Olivier, C., Lézot, F., Oliver, L., Cochonneau, D., Lalier, L., Cartron, P.-F., & Heymann, D. (2019). Dormant, quiescent, tolerant and persister cells: Four synonyms for the same target in cancer. Biochemical Pharmacology, 162, 169–176. https://doi.org/10.1016/j.bcp.2018.11.004
Aguirre-Ghiso, J. A. (2007). Models, mechanisms and clinical evidence for cancer dormancy. Nature Reviews Cancer, 7(11), 834–846. https://doi.org/10.1038/nrc2256
Sosa, M. S., Bragado, P., & Aguirre-Ghiso, J. A. (2014). Mechanisms of disseminated cancer cell dormancy: an awakening field. Nature Reviews Cancer, 14(9), 611–622. https://doi.org/10.1038/nrc3793
Roesch, A., Vultur, A., Bogeski, I., Wang, H., Zimmermann, K. M., Speicher, D., Körbel, C., Laschke, M. W., Gimotty, P. A., Philipp, S. E., et al. (2013). Overcoming intrinsic multidrug resistance in melanoma by blocking the mitochondrial respiratory chain of slow-cycling JARID1B(high) cells. Cancer Cell, 23(6), 811–825. https://doi.org/10.1016/j.ccr.2013.05.003
Jin, X., Demere, Z., Nair, K., Ali, A., Ferraro, G. B., Natoli, T., Deik, A., Petronio, L., Tang, A. A., Zhu, C., et al. (2020). A metastasis map of human cancer cell lines. Nature, 588(7837), 331–336. https://doi.org/10.1038/s41586-020-2969-2
Ward, P. S., & Thompson, C. B. (2012). Metabolic reprogramming: A cancer hallmark even warburg did not anticipate. Cancer Cell, 21(3), 297–308. https://doi.org/10.1016/j.ccr.2012.02.014
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008). The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation. Cell Metabolism, 7(1), 11–20. https://doi.org/10.1016/j.cmet.2007.10.002
DeNicola, G. M., & Cantley, L. C. (2015). Cancer’s fuel choice: New flavors for a picky eater. Molecular cell, 60(4), 514–523. https://doi.org/10.1016/j.molcel.2015.10.018
Reinfeld, B. I., Madden, M. Z., Wolf, M. M., Chytil, A., Bader, J. E., Patterson, A. R., Sugiura, A., Cohen, A. S., Ali, A., Do, B. T., et al. (2021). Cell-programmed nutrient partitioning in the tumour microenvironment. Nature, 593(7858), 282–288. https://doi.org/10.1038/s41586-021-03442-1
Lum, J. J., Bauer, D. E., Kong, M., Harris, M. H., Li, C., Lindsten, T., & Thompson, C. B. (2005). Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell, 120(2), 237–248. https://doi.org/10.1016/j.cell.2004.11.046
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009). Understanding the Warburg effect: The metabolic requirements of cell proliferation. Science, 324(5930), 1029–1033. https://doi.org/10.1126/science.1160809
Endo, H., Okuyama, H., Ohue, M., & Inoue, M. (2014). Dormancy of cancer cells with suppression of AKT activity contributes to survival in chronic hypoxia. PLOS ONE, 9(6), e98858. https://doi.org/10.1371/journal.pone.0098858
Assaily, W., Rubinger, D. A., Wheaton, K., Lin, Y., Ma, W., Xuan, W., Brown-Endres, L., Tsuchihara, K., Mak, T. W., & Benchimol, S. (2011). ROS-mediated p53 induction of Lpin1 regulates fatty acid oxidation in response to nutritional stress. Molecular Cell, 44(3), 491–501. https://doi.org/10.1016/j.molcel.2011.08.038
Zaugg, K., Yao, Y., Reilly, P. T., Kannan, K., Kiarash, R., Mason, J., Huang, P., Sawyer, S. K., Fuerth, B., Faubert, B., et al. (2011). Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress. Genes & Development, 25(10), 1041–1051. https://doi.org/10.1101/gad.1987211
Wang, C., Li, Z., Lu, Y., Du, R., Katiyar, S., Yang, J., Fu, M., Leader, J. E., Quong, A., Novikoff, P. M., et al. (2006). Cyclin D1 repression of nuclear respiratory factor 1 integrates nuclear DNA synthesis and mitochondrial function. Proceedings of the National Academy of Sciences, 103(31), 11567–11572. https://doi.org/10.1073/pnas.0603363103
Lopez-Mejia, I. C., Lagarrigue, S., Giralt, A., Martinez-Carreres, L., Zanou, N., Denechaud, P.-D., Castillo-Armengol, J., Chavey, C., Orpinell, M., Delacuisine, B., et al. (2017). CDK4 phosphorylates AMPKα2 to inhibit its activity and repress fatty acid oxidation. Molecular Cell, 68(2), 336–349.e6. https://doi.org/10.1016/j.molcel.2017.09.034
Toyama, E. Q., Herzig, S., Courchet, J., Lewis, T. L., Losón, O. C., Hellberg, K., Young, N. P., Chen, H., Polleux, F., Chan, D. C., et al. (2016). AMP-activated protein kinase mediates mitochondrial fission in response to energy stress. Science, 351(6270), 275–281. https://doi.org/10.1126/science.aab4138
Camarda, R., Zhou, A. Y., Kohnz, R. A., Balakrishnan, S., Mahieu, C., Anderton, B., Eyob, H., Kajimura, S., Tward, A., Krings, G., et al. (2016). Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer. Nature Medicine, 22(4), 427–432. https://doi.org/10.1038/nm.4055
Madak-Erdogan, Z., Band, S., Zhao, Y. C., Smith, B. P., Kulkoyluoglu-Cotul, E., Zuo, Q., Santaliz Casiano, A., Wrobel, K., Rossi, G., Smith, R. L., et al. (2019). Free fatty acids rewire cancer metabolism in obesity-associated breast cancer via estrogen receptor and mTOR signaling. Cancer Research, canres.2849.2018. https://doi.org/10.1158/0008-5472.CAN-18-2849
Havas, K. M., Milchevskaya, V., Radic, K., Alladin, A., Kafkia, E., Garcia, M., Stolte, J., Klaus, B., Rotmensz, N., Gibson, T. J., et al. (2017). Metabolic shifts in residual breast cancer drive tumor recurrence. Journal of Clinical Investigation, 127(6), 2091–2105. https://doi.org/10.1172/JCI89914
Fox, D. B., Garcia, N. M. G., McKinney, B. J., Lupo, R., Noteware, L. C., Newcomb, R., Liu, J., Locasale, J. W., Hirschey, M. D., & Alvarez, J. V. (2020). NRF2 activation promotes the recurrence of dormant tumour cells through regulation of redox and nucleotide metabolism. Nature Metabolism, 2(4), 318–334. https://doi.org/10.1038/s42255-020-0191-z
Shen, S., Faouzi, S., Souquere, S., Roy, S., Routier, E., Libenciuc, C., André, F., Pierron, G., Scoazec, J.-Y., & Robert, C. (2020). Melanoma persister cells are tolerant to BRAF/MEK inhibitors via ACOX1-mediated fatty acid oxidation. Cell Reports, 33(8), 108421. https://doi.org/10.1016/j.celrep.2020.108421
Hampsch, R. A., Wells, J. D., Traphagen, N. A., McCleery, C. F., Fields, J. L., Shee, K., Dillon, L. M., Pooler, D. B., Lewis, L. D., Demidenko, E., et al. (2020). ampk activation by metformin promotes survival of dormant ER + breast cancer cells. Clinical Cancer Research, 26(14), 3707–3719. https://doi.org/10.1158/1078-0432.CCR-20-0269
Luo, Z., Zang, M., & Guo, W. (2010). AMPK as a metabolic tumor suppressor: control of metabolism and cell growth. Future Oncology, 6(3), 457–470. https://doi.org/10.2217/fon.09.174
Li, Y., Liang, R., Sun, M., Li, Z., Sheng, H., Wang, J., Xu, P., Liu, S., Yang, W., Lu, B., et al. (2020). AMPK-dependent phosphorylation of HDAC8 triggers PGM1 expression to promote lung cancer cell survival under glucose starvation. Cancer Letters, 478, 82–92. https://doi.org/10.1016/j.canlet.2020.03.007
Naik, P. P., Mukhopadhyay, S., Praharaj, P. P., Bhol, C. S., Panigrahi, D. P., Mahapatra, K. K., Patra, S., Saha, S., Panda, A. K., Panda, K., et al. (2021). Secretory clusterin promotes oral cancer cell survival via inhibiting apoptosis by activation of autophagy in AMPK/mTOR/ULK1 dependent pathway. Life Sciences, 264, 118722. https://doi.org/10.1016/j.lfs.2020.118722
Ferretti, A. C., Tonucci, F. M., Hidalgo, F., Almada, E., Larocca, M. C., & Favre, C. (2016). AMPK and PKA interaction in the regulation of survival of liver cancer cells subjected to glucose starvation. Oncotarget, 7(14), 17815–17828. https://doi.org/10.18632/oncotarget.7404
Chaube, B., Malvi, P., Singh, S. V., Mohammad, N., Viollet, B., & Bhat, M. K. (2015). AMPK maintains energy homeostasis and survival in cancer cells via regulating p38/PGC-1α-mediated mitochondrial biogenesis. Cell Death Discovery, 1(1), 1–11. https://doi.org/10.1038/cddiscovery.2015.63
Peart, T., Valdes, Y. R., Correa, R. J. M., Fazio, E., Bertrand, M., McGee, J., Préfontaine, M., Sugimoto, A., DiMattia, G. E., & Shepherd, T. G. (2015). Intact LKB1 activity is required for survival of dormant ovarian cancer spheroids. Oncotarget, 6(26), 22424–22438.
You, B., Xia, T., Gu, M., Zhang, Z., Zhang, Q., Shen, J., Fan, Y., Yao, H., Pan, S., Lu, Y., et al. (2022). AMPK–mTOR–mediated activation of autophagy promotes formation of dormant polyploid giant cancer cells. Cancer Research, 82(5), 846–858. https://doi.org/10.1158/0008-5472.CAN-21-2342
Lu, Z., Luo, R. Z., Lu, Y., Zhang, X., Yu, Q., Khare, S., Kondo, S., Kondo, Y., Yu, Y., Mills, G. B., et al. (2008). The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells. The Journal of Clinical Investigation, 118(12), 3917–3929. https://doi.org/10.1172/JCI35512
Kim, S. M., Nguyen, T. T., Ravi, A., Kubiniok, P., Finicle, B. T., Jayashankar, V., Malacrida, L., Hou, J., Robertson, J., Gao, D., et al. (2018). PTEN deficiency and AMPK activation promote nutrient scavenging and anabolism in prostate cancer cells. Cancer Discovery, 8(7), 866–883. https://doi.org/10.1158/2159-8290.CD-17-1215
Glatz, J. F. C., & Luiken, J. J. F. P. (2020). Time for a détente in the war on the mechanism of cellular fatty acid uptake. Journal of Lipid Research, 61(9), 1300–1303. https://doi.org/10.1194/jlr.6192020LTE
Ladanyi, A., Mukherjee, A., Kenny, H. A., Johnson, A., Mitra, A. K., Sundaresan, S., Nieman, K. M., Pascual, G., Benitah, S. A., Montag, A., et al. (2018). Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis. Oncogene, 37(17), 2285–2301. https://doi.org/10.1038/s41388-017-0093-z
Zhao, J., Zhi, Z., Wang, C., Xing, H., Song, G., Yu, X., Zhu, Y., Wang, X., Zhang, X., & Di, Y. (2017). Exogenous lipids promote the growth of breast cancer cells via CD36. Oncology Reports, 38(4), 2105–2115. https://doi.org/10.3892/or.2017.5864
Drury, J., Rychahou, P. G., He, D., Jafari, N., Wang, C., Lee, E. Y., Weiss, H. L., Evers, B. M., & Zaytseva, Y. Y. (2020). Inhibition of fatty acid synthase upregulates expression of cd36 to sustain proliferation of colorectal cancer cells. Frontiers in Oncology, 10 Retrieved from https://www.frontiersin.org/article/10.3389/fonc.2020.01185
Farge, T., Saland, E., de Toni, F., Aroua, N., Hosseini, M., Perry, R., Bosc, C., Sugita, M., Stuani, L., Fraisse, M., et al. (2017). Chemotherapy-resistant human acute myeloid leukemia cells are not enriched for leukemic stem cells but require oxidative metabolism. Cancer Discovery, 7(7), 716–735. https://doi.org/10.1158/2159-8290.CD-16-0441
Pascual, G., Avgustinova, A., Mejetta, S., Martín, M., Castellanos, A., Attolini, C. S.-O., Berenguer, A., Prats, N., Toll, A., Hueto, J. A., et al. (2017). Targeting metastasis-initiating cells through the fatty acid receptor CD36. Nature, 541(7635), 41–45. https://doi.org/10.1038/nature20791
Landberg, N., von Palffy, S., Askmyr, M., Lilljebjörn, H., Sandén, C., Rissler, M., Mustjoki, S., Hjorth-Hansen, H., Richter, J., Ågerstam, H., et al. (2018). CD36 defines primitive chronic myeloid leukemia cells less responsive to imatinib but vulnerable to antibody-based therapeutic targeting. Haematologica, 103(3), 447–455. https://doi.org/10.3324/haematol.2017.169946
留言 (0)